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The Escherichia coli proteins DksA, 
GreA and GreB are all structural homologs 
that bind the secondary channel of RNA 
polymerase (RNAP) but are thought to act at 
different levels of transcription. DksA, with its 
co-factor ppGpp, inhibits rrnB P1 transcription 
initiation while GreA and GreB activate RNAP 
to cleave backtracked RNA during elongational 
pausing. Here, in vivo and in vitro evidence 
reveals antagonistic regulation of rrnB P1 
transcription initiation by Gre factors 
(particularly GreA) and DksA; GreA activates 
and DksA inhibits. DksA inhibition is epistatic 
to GreA activation. Both modes of regulation 
are ppGpp-independent in vivo but DksA 
inhibition requires ppGpp in vitro. Kinetic 
experiments and studies of rrnB P1-RNA 
polymerase complexes suggest that GreA 
mediates conformational changes at an 
initiation step in the absence of NTP substrates, 
even before DksA acts. GreA effects on rrnB P1 
open complex conformation reveal a new 
feature of GreA distinct from its general 
function in elongation. Our findings support 
the idea that a balance of the interactions 
between the three secondary channel binding 
proteins and RNAP can provide a new mode 
for regulating transcription. 
 
Structural and functional studies of 
bacterial and eukaryotic RNA polymerases 
(RNAP)3 reveal an emerging class of 
transcriptional regulators: proteins that interact 
directly with the secondary channel - GreA, GreB, 
DksA, TFIIS, Microcin J25, and Gfh1 (for review 
see 1; 2, 3, 4). The secondary channel itself is 
thought to provide NTP access to a stably bound 
Mg2+ ion in the catalytic center of RNAP when 
template DNA and the nascent RNA-DNA hybrid 
occlude the main channel (5, 6). Multiple 
transcription factors acting at a common site on 
RNAP raise possibilities of new modes of 
transcription regulation (review, 7). 
GreA and GreB are bacterial protein 
homologs with shared N-terminal alpha-helical 
coiled-coil finger structures that penetrate the 
secondary channel and juxtapose two acidic 
residues near the catalytic center; the C-terminal 
globular domains are implicated in RNAP binding 
(8, 9). Yeast RNA polymerase II transcription 
factor TFIIS, although structurally distinct from 
GreA and GreB (10), also positions a pair of 
conserved acidic amino acid residues near the 
catalytic center. In all cases, these acidic residues 
activate an intrinsic RNA phosphodiesterase 
activity of RNAP paused during elongation, 
leading to cleavage of nascent RNA, whose 3' end 
has threaded backwards relative to the catalytic 
center; this cleavage creates a 3’ hydroxyl near the 
catalytic center and restores the possibility of 
polymerization (11, 12, 13). Despite their 
structural similarities, GreA and GreB are 
functionally different. The length of RNA 
cleavage products differs and GreA, but not GreB, 
needs to bind before arrest in order to activate 
RNA cleavage (14, 15). Functions proposed for 
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Gre factors include: facilitating promoter escape 
by suppressing abortive transcription; suppressing 
elongational pausing or arrest; and enhancing 
proofreading (16; review, 1).  Although blocking 
the passage of NTP substrates by binding of Gre 
factors has not been shown, channel binding by 
the structurally unique Microcin J25 antibacterial 
peptide is thought to inhibit transcription 
elongation directly by obstructing NTP entry (2; 
17).  
Transcription initiation can also be 
regulated through the secondary channel by DksA 
and (p)ppGpp, 3’-pyrophosphorylated derivatives 
of GDP (GTP). First, (p)ppGpp, a nearly 
ubiquitous nucleotide regulator of transcription in 
eubacteria and in plants, can be localized by co-
crystallization with RNAP near the catalytic center 
(18). Second, DksA, despite a divergent aminoacid 
sequence, is a structural homolog of GreA and 
GreB. This allows similar modeling in the 
secondary channel and a proposal of nearly 
appropriate placement of the key pair of conserved 
acidic residues (19). Third, DksA and ppGpp can 
function both in vitro and in vivo as synergistic co-
factors for negative as well as positive regulation 
of transcription initiation (19, 20, 21, 22). 
Although it requires reorientation of the pair of 
acidic residues, it has been proposed that DksA 
might anchor (p)ppGpp in one of two possible 
orientations near the catalytic center through Mg2+ 
ions jointly coordinated by ppGpp pyrophosphate 
residues, thereby stabilizing the bound co-factor 
and potentiating its regulatory effects (19). 
Whether the regulatory effect of ppGpp and DksA 
is positive or negative seems largely specified by 
the promoter discriminator sequence between the -
10 and +1 region, as predicted long ago (23). 
DksA and ppGpp exert strong negative regulation 
of rrnB P1 and other ribosomal RNA promoters. 
This regulation is argued to result from enhanced 
destabilization and closure of RNAP - rrnB P1 
promoter open complexes together with weakened 
dependence on the initiating NTP (review, 22).  
Positive regulation of some promoters for amino 
acid biosynthetic genes is attributed mainly to 
increasing the rate of isomerization between 
closed and open complexes (21).  
Here, we present experiments designed to 
test the hypothesis that the three secondary 
channel binding proteins (GreA/B, DksA) can 
mutually compete for RNA polymerase despite 
known differences in the step of transcription at 
which they function.  
 
EXPERIMENTAL PROCEDURES 
 
Growth conditions, strains and plasmids: 
Escherichia coli K-12 strains used in this work 
(Table S1) were grown in LB broth at 37oC with 
appropriate antibiotic concentrations as follows: 
chloramphenicol (Cm) 20 µg/ml; kanamycin (Km) 
40 µg/ml; tetracycline (Tc) 20 µg/ml; ampicillin 
(Ap) 100 µg/ml; spectinomycin (Sp) 50 µg/ml. 
Strains were constructed by P1vir transduction 
(24) with the following donors: CF1693 (25) as a 
source for ∆spoT207::cat, ∆relA251::kan. Strains 
CLT254, as a source of greA::cat, and CLT255, as 
a source of greB::kan, were obtained from Dr. R. 
Weisberg. 
 Plasmid pBW, containing the rrnB P1P2 
region spanning from –235 bp to +237 bp (using 
P1 as a reference) was constructed by removing a 
370 bp rrnB T1T2 terminator fragment from 
plasmid pPS1 (26) and ligating it to an EcoRI and 
HindIII fragment containing the rrnB P1P2 region 
from –235 bp to +237 bp (obtained by PCR using 
chromosomal DNA templates). The rrnB P1 
promoter template (-180 bp to +109 bp) was 
generated by PCR using pBW plasmid as template 
and the following primers: rrnB-180 (5’-
TGCCTTTTGTATGGCAATGAC-3’) and 
rrnB+109 (5’-AATACGCCTTCCCGCTACA-3’). 
The ensuing 289 bp fragment was purified using 
High Pure PCR Product Purification Kit (Roche 
Diagnostics) before use as template. We elected to 
use a linear template with a single promoter for all 
assays because inhibitory functions of DksA on 
rrnB P1 have been reported to be independent of 
superhelicity of the DNA template (21).   
Plasmid pHM1506 was derived from 
pGB2 with a PSC101 origin conferring 
spectinomycin resistance (27) and was modified to 
contain lacIq and used for expressing native dksA 
from the Ptac promoter. For purification of C-
terminal His-tagged DksA, pHM1501 was 
constructed by PCR cloning of the dksA orf from 
pJK537 (28) in pET21 (Novagen). The inability of 
the ∆dksA strain CF9239 to grow on glucose 
minimal medium is complemented by pHM1506.  
Plasmids used for in vivo experiments as well as 
purification of native GreA and native GreB were 
pDNL278 and pGF296 respectively (29). 
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β-galactosidase Assays - Assays for reporter 
activity were as described (24).  
 
Protein Purification – His-DksA encoded by 
pHM1501 was purified with Ni2+-NTA-agarose 
columns as described by Qiagen, then dialyzed 
against storage buffer (0.2 M Tris-Cl, pH 7.9, 0.05 
M EDTA, 0.1 mM DTT, 0.1 M NaCl, 50% 
glycerol). GreA and GreB were purified as 
described in (29). 
 
In Vitro Transcription - Transcription assays were 
performed in a reaction volume of 20 µl at 30°C, 
using 10 nM template and 30 nM RNAP ( E. coli 
holoenzyme from Epicentre Technologies) in 
buffer containing 50 mM Tris-acetate (pH 8.0), 10 
mM MgAc, 10 mM β-mercapthoethanol, 10 µg/ml 
bovine serum albumin, 90 mM potassium 
glutamate, 100 µM ATP, GTP, and CTP, and 10 
µM UTP (10 µCi/reaction [α-32P] UTP, 
Amersham), and either 250 µM GDP or 250 µM 
ppGpp. RNAP was pre-incubated (25o C) with 
GDP or ppGpp for 7 min prior to the addition of 
potassium glutamate, and unless stated otherwise, 
this was followed by 7 min incubation at 30°C 
with DNA and the indicated GreA and/or DksA 
concentrations (0-600 nM). The reactions were 
initiated by adding NTP substrates and terminated 
after 10 minutes by the addition of an equal 
volume of stop solution (95% formamide, 20 mM 
EDTA, 0.05% bromophenol blue, and 0.05% 
xylene cyanol).  In experiments varying the order 
of addition of GreA and DksA, the protein added 
first was pre-incubated with RNAP and DNA, and 
the second protein was added together with NTPs. 
In single round experiments, 100 µg/ml heparin 
was added. Samples were analyzed on 7 M urea, 
6% polyacrylamide sequencing gels and quantified 
by phosphorimaging on a Molecular Dynamics 
imaging system.  
 
Promoter Escape and Open Complex Stability 
Assays - Promoter escape and open complex 
stability assays were as described in (30), except 
that the buffer conditions, RNAP and DNA 
concentrations were as specified above. 
 
DNaseI Footprinting Assay - End labeled DNA 
fragments were generated by PCR using 32P-end-
labeled rrnB-180 and unlabeled rrnB+109 primers, 
and purified using the High Pure PCR Product 
Purification Kit (Roche Diagnostics). RNAP (0-
100 nM) was pre-incubated with 500 µM GDP, or 
ppGpp, at room temperature for 7 min in 
transcription buffer, then labeled DNA template (3 
nM final) was added together with potassium 
glutamate (90 mM final), 600 nM GreA and/or 
600 nM DksA. The final reaction volume was 20 
µl. Reaction mixtures were incubated at 37°C for 
15 min, treated with DNaseI (7.5 ng/reaction; 
Promega Corporation) for 6 min, terminated by 
addition of EDTA (25 mM final), concentrated by 
vacuum evaporation, and resuspended in 20 µl 
loading buffer (80% formamide, 6 M urea, 10 mM 
NaOH, 0.05% bromophenol blue, and 0.05% 
xylene cyanol). The samples were resolved on 7 M 
urea, 8% polyacrylamide sequencing gels, run in 
parallel with sequencing reactions obtained by 
using unlabeled DNA fragment as a template with 
32P-end-labeled rrnB-180 primer. 
 
KMnO4 Footprinting Assay - KMnO4 footprinting 
of the open complexes was performed as described 
in (30), except that the open complexes were 
allowed to form for 15-30 minutes before 
incubating under reaction conditions described 
above for the DNaseI footprinting. When specified, 
ATP and CTP were added at 100 µM each. 
 
Electrophoretic mobility shift assays (EMSA) -
These studies were performed as described in (31). 
When employed, ppGpp was added at 500 µM, 
GreA concentration was 600 nM. The template 
concentration was 3 nM, and RNAP concentration 
was varied. 
 
RESULTS 
 
DksA and GreA/B effects in vivo. The structural 
study of GreA, GreB, and DksA suggests that they 
might compete for their interactions with RNAP. 
We tested this hypothesis in vivo, using an rrnB 
P1::lacZ ribosomal promoter operon fusion (32, 
33) known to be negatively regulated by DksA and 
ppGpp (22). Plasmids allowing IPTG-inducible 
Ptac driven expression of native GreA (pDNL278), 
GreB (pGF296), or DksA (pHM1506) (Fig. 1, top, 
middle, lower rows) were introduced into strains 
with or without ppGpp (columns 1, 2 and 3, 4, 
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respectively). Reporter activities were measured 
during a cycle of growth in LB broth, with or 
without IPTG. We also introduced mutations into 
each series of strains eliminating potential 
competing proteins (columns 2, 4). Figure 1 shows 
differential plots of reporter activities vs turbidity 
(A600) during growth cycles. For sufficiently low 
values of A600, these curves are approximately 
linear; the slope of such a curve is the differential 
rate of synthesis; these values are given in Table I, 
expressed as Miller units (24). 
Looking first at the untransformed strains 
in exponential phase, it can be seen (Table I) that 
loss of DksA increased rrnB P1 transcription 2.4-
fold over the wild type level, whether ppGpp was 
present or not. This confirms that DksA is a 
negative regulator of rrnB P1 transcription. Loss 
of GreA, in contrast, had no effect. Figure 1 also 
shows that the promoter activity of the wild type 
strain shut-down when a critical cell density was 
reached (A600~2.0). No arrest was observed in the 
absence of DksA and arrest occurred later in the 
absence of ppGpp. Despite uncertainties regarding 
an absolute requirement for ppGpp during entry 
into stationary phase, this is qualitatively 
consistent with a requirement for both ppGpp and 
DksA to restrict P1 transcription late in growth in 
LB broth (34, 28, 20).  
The same arrest was observed at high cell 
densities when the strains were transformed with 
the three plasmids, so long as the plasmids were 
uninduced. Major differences were observed, 
however, when the proteins were induced with 
IPTG. Some induced conditions were 
unexpectedly inhibitory for growth, such as 
inducing GreA (but not GreB) in a dksA mutant 
and inducing DksA in all strains. We therefore 
reduced the inducing concentration of IPTG from 
the standard 1 mM to 0.01 mM (panels B,D) or 0.1 
mM (panels I-L). These adjustments of IPTG also 
yield roughly similar levels of each protein that 
approximate the staining intensities of the most 
abundant E. coli proteins in crude extracts 
(Supplement Fig. S1).  
In wild type cells, increasing GreA levels 
activated rrnB P1 transcription (Fig. 1A, Table I). 
Simply transforming the wild type strain with 
pgreA mildly elevated the specific activity 1.4x 
(+/- ppGpp) and IPTG induction further activated 
for a total of 3.4x. A dksA mutation in the 
otherwise wild type strain increased its specific 
activity 2.4x and transforming with pgreA further 
activated 1.4x (in the absence of ppGpp), again for 
a total of 3.4x. In this case however, no further 
activation was observed after IPTG addition, but 
rather a slight decrease (from 250 U to 211 
U).This did not result from a difference in GreA 
expression in the dksA mutant: protein staining 
indicated that the mutant did not induce GreA 
without IPTG but induced it normally when IPTG 
was added (Fig. S1). That equal levels of rrnB P1 
activation occur at such different levels of GreA 
may mean that activation has reached a saturation 
limit. Indeed, this specific activity limit of 251 U 
was exceeded only once, 294 U, in an uninduced 
dksA mutant in the absence of ppGpp (Table I). 
Nevertheless, the activation of rrnB P1 by GreA 
(at its uninduced level) is potentiated by the 
absence of DksA.  
Comparing the middle row of panels in 
Fig. 1 to the top row reveals that the pgreB 
plasmid had little effect in the absence of inducer. 
Even with IPTG, activation of rrnB P1 promoter 
activity was not observed in the wild type strain 
(Fig. 1A,E) and was barely noticeable in the dksA+ 
ppGpp0 strain (Fig. 1G). However, inducing the 
pgreB plasmid did alleviate the rrnB P1 arrest late 
in the growth cycle (Fig. 1E). Panels F and H 
show that the dksA mutant again failed to arrest, as 
in panels B and D.  
Shortly after addition of IPTG to growing 
cells containing pdksA, reporter expression 
abruptly stopped in all strains (Fig. 1I-L); this 
arrest in rrnB P1 activity did not require ppGpp or 
GreA. Note that the ordinate scale in the last row 
of panels (I-L) is amplified 4x relative to upper 
row panels to contrast inhibition of rrnB P1 
transcription with low activity levels. The block of 
rrnB P1 transcription when DksA was 
overexpressed was both more rapid and more 
complete than the growth limitation observed 
under these conditions. 
These results are compatible with the 
hypothesis that DksA and GreA compete with 
each other, the latter activating rrnB P1 
transcription, the former inhibiting it. They can be 
viewed as non-physiological responses because of 
the abnormally high level of IPTG induced 
proteins. If physiological function requires a 
balanced ratio of proteins then simultaneous 
induction of putative protein competitors should 
eliminate changes in promoter regulation. To test 
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this, we constructed strains with two compatible 
plasmids allowing IPTG induction of both DksA 
(pHM1506) and GreA (pDNL278). Co-induction 
of DksA and GreA activated rrnB P1 much the 
same as inducing GreA alone, overriding 
inhibitory effects of DksA alone (Supplement Fig. 
S2). Co-induction of GreB and DksA protected 
from inhibitory effects of DksA, but did not 
activate like GreA (Supplement Fig. S2). 
Evidently, balanced levels of these proteins have 
physiological effects regardless of their absolute 
concentration. 
These in vivo experiments confirm the 
negative effect of DksA on rrnB P1 activity and 
suggest that excess GreA, and to a lesser extent 
excess GreB, can counteract it. We now ask 
whether these observations can be reproduced and 
understood in a purified transcription system. 
 
GreA activation, not DksA inhibition, requires its 
presence during open complex formation. We first 
asked whether GreA stimulation and DksA 
inhibition of rrnB P1 transcription occurs during 
multiround transcription using purified GreA and 
DksA proteins (see Experimental Procedures). All 
transcription experiments employed GDP as a 
control for the effects of ppGpp.  Initially, RNAP 
(30 nM) was pre-incubated with 250 µM ppGpp 
(or 250 µM GDP) together with increasing 
amounts of GreA, and the reaction was initiated by 
addition of 10 nM DNA template and NTP 
substrates. We reasoned that since GreA is 
implicated in binding to the RNAP secondary 
channel, preincubation with RNAP might increase 
its ability to interact with RNAP and activate. 
However, preincubating with even a 10-fold molar 
excess of GreA over RNAP did not stimulate 
transcription (Fig. 2A). Pre-incubating RNAP with 
only ppGpp (or GDP) and initiating the reaction 
with GreA, template and substrates also failed to 
reveal GreA activation (Fig. 2B). A modest 
activation at higher amounts of GreA was noted 
when the reaction was initiated with GreA and 
NTPs (Fig. 2C). It became clear that to achieve 
maximum activation (2x to 2.5x), GreA had to be 
present during open complex formation, i.e. in the 
presence of template, starting the reaction with 
NTPs (Fig. 2D). As observed in vivo, activation 
did not require ppGpp but was seen using a 5- to 
10-fold molar excess of GreA over RNAP (Fig. 
2D). 
Figure 2 also shows the results of similar 
assays with DksA that affirm its ability to inhibit 
rrnB P1 transcription, again at a 5- to 10-fold 
molar excess over RNAP. Unlike in vivo inhibition 
by DksA, in vitro inhibition requires ppGpp (Fig. 
2, A-D). Clear ppGpp-dependent inhibition was 
seen under all conditions tested (Fig. 2, A-D), with 
a somewhat stronger effect when the reactions 
were started with NTPs. Evidently GreA activates 
and DksA inhibits rrnB P1 transcription in vitro. 
Experiments similar to those shown in Fig. 2 were 
performed with GreB and slight activation was 
observed with or without ppGpp (data not shown), 
consistent with data in Fig.1. 
 
Simultaneous vs serial addition of GreA and DksA. 
We next performed reactions similar to those of 
Fig. 2C, but asking whether GreA and DksA 
compete for RNAP at the rrnB P1 promoter. First, 
GreA and DksA at concentrations varying from 30 
to 600 nM were presented simultaneously to a 
fixed concentration of 30 nM RNAP and 10 nM 
DNA with ppGpp or GDP, with reactions initiated 
by substrate addition (Fig. 3A, B). The first set of 
reactions showed that DksA with ppGpp could 
overcome stimulation by GreA even when present 
in significantly lower concentrations than GreA 
(Fig. 3A).  In the absence of ppGpp, however, 
DksA was no longer able to overcome GreA 
activation even at a 20-fold molar excess of DksA 
over RNAP (Fig. 3B). This is consistent with a 
strong ppGpp co-factor requirement in vitro for 
DksA inhibition but not with the ppGpp-
independent inhibition observed in vivo when 
DksA was overproduced (Fig. 1J, L). Similar 
results were obtained when these experiments 
were repeated but allowing only a single round of 
transcription (data not shown).  
We then asked whether allowing the first 
protein to be present during open complex 
formation could be reversed by a brief exposure to 
the second protein. This was accomplished under 
conditions similar to Fig. 2D, but utilizing single 
round assays and initiating the reaction by the 
addition of the second protein together with NTP 
substrates (Fig. 3C-F). When GreA was added first 
in the presence of ppGpp, the activation by even a 
20-fold molar excess of GreA over RNAP was 
progressively abolished by initiating the reaction 
with increasing amounts of DksA, NTP substrates, 
and heparin (Fig. 3C).  Again, this reversal 
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required the presence of ppGpp (Fig. 3D). In 
contrast, even a 20-fold molar excess of GreA 
over RNAP did not reverse DksA inhibition in the 
presence of ppGpp (Fig. 3E). This was not simply 
because the stimulatory effect of GreA was 
abolished when it was added after open complexes 
had formed since control experiments with GDP 
show that GreA was able to activate rrnB P1 under 
similar conditions (Fig. 3F), although to a lesser 
extent than in Fig. 3B, D. Taken together, these 
experiments support the conclusion that, in the 
presence of ppGpp, transcription inhibition by 
DksA is dominant over in vitro activation of the 
rrnB P1 promoter by GreA 
GreA and DksA effects on RNAP-DNA complex 
conformation. We next wished to document that 
the GreA- and/or DksA-sensitive steps in rrnB P1 
transcription do indeed both occur at a stage of 
initiation, as implied by Fig. 3, by asking whether 
there are conformational changes in open 
complexes formed in the presence of these 
transcription regulators. Open binary complexes of 
rrnB P1 promoters and RNAP previously have 
been reported as too unstable for footprinting 
unless ternary complexes are created by a limited 
number of phosphodiester bonds in the presence of 
ATP and CTP (35). Nevertheless, we were able to 
obtain DNaseI footprints with RNA polymerase on 
double stranded DNA labeled on the 5' end of the 
nontemplate strand. Footprints in the absence of 
initiating substrates are shown in Fig. 4A using 
varying amounts of RNAP, 500 µM ppGpp or 
GDP, with or without 600 nM GreA and DksA 
added alone, simultaneously, or serially. We found 
protection with RNAP alone, with ppGpp or with 
GDP extending from -57 to about +30 (Fig. 4A, 
lanes 1-3). This protection pattern was not 
appreciably altered by adding DksA, whether 
alone, with GDP, or with ppGpp (Fig. 4A, lanes 4-
6, 7-9, 19-21; Fig. 5AB). Adding GreA, especially 
in the presence of ppGpp (as compared to GDP) 
reduced DNaseI protection in the region from -35 
to +30 (Fig. 4A, lanes 10-12, 22-24; Fig. 5AB). 
Adding DksA after preincubating GreA with 
RNAP and ppGpp largely eliminated the reduced 
protection by GreA, thereby restoring the DNaseI 
footprint to one characteristic of RNAP alone (Fig. 
4A, lanes 2-3, 13-15, 25-27; Fig. 5AB). Adding 
DksA simultaneously with GreA (with ppGpp) 
seemed slightly less effective at reversing the 
GreA footprint change than adding DksA last (Fig. 
4A, lanes 25-27, 28-30; Fig. 5B).  
These experiments were repeated with 
ATP and CTP present to allow formation of initial 
RNA diesters and stabilization of RNAP-DNA 
open complexes (35) (Fig. 4B, Fig. 5CD). 
Protection patterns were similar except that GreA 
reversed protection now only in the -35 to -10 
region (while protection persisted from -10 to +30) 
(Fig. 4B, lanes 10-12, 22-24; Fig. 5CD). Another 
difference is that the ppGpp specificity of GreA 
effects shown in Fig. 4A disappears in Fig. 4B; 
reversal of protection occurred in the presence of 
GDP as well as with ppGpp. DksA alone had no 
effect on the protection pattern of RNA 
polymerase (+/- ppGpp), but DksA in the presence 
of ppGpp restored the protection diminished by 
GreA (compare pairs of lanes 11-12, 14-15 and 
17-18 with 23-24, 26-27 and 29-30 Fig. 4B; Fig. 
5CD). This conclusion is in agreement with results 
presented in Fig. 3 where DksA was unable to 
overcome effects of GreA in the absence of ppGpp. 
The fact that GreA induces a change in the 
footprint in the presence of ppGpp but not GDP 
(Fig. 4A, compare lanes 23-24 and 11-12) may 
indicate an additional effect of GreA to overcome 
the negative effect of ppGpp and to activate 
transcription. To confirm the promoter specificity 
of the footprints, similar experiments were 
performed with a template bearing scrambled rrnB 
P1 -10 and -35 regions; even in the presence of 
ATP and CTP no DNaseI protection was obtained 
(data not shown). Note that GreA and DksA 
yielded no observable footprint in the absence of 
RNAP (Fig.4 AB). 
We also performed KMnO4 footprinting to 
ask whether single stranded DNA was generated 
by conditions similar to those presented in Fig. 4A. 
These footprints were found to be weak without 
ATP and CTP but unchanged by GreA and DksA. 
Parallel studies of stable complexes in the 
presence of ATP and CTP, similar to Fig. 4B, also 
did not reveal GreA- or DksA-dependent 
differences (data not shown). This implies that the 
DNaseI footprints in Fig. 4A reflect the formation 
of open complex intermediates and that the single 
stranded DNA bubbles are unchanged in the stable 
open complexes visualized in Fig. 4B.  The effects 
of GreA on the extent of open complex formation 
seemed minimal from electrophoretic mobility 
This is an author-prepared PDF of a paper published in Journal of Biological Chemistry (2006) 281:15238-48
 7
shift assays without NTP substrates (Fig. 6A). In 
the presence of ATP and CTP a more striking 
effect of GreA on the formation of complex III 
was found (Fig. 6B), suggesting a more lasting 
conformational effect (as visualized in Figs. 4B, 
5CD). Complex III is judged to be the only active 
complex seen, as seen from its unique 
disappearance in the presence of all four NTP 
substrates (data not shown). 
We were surprised that DksA did not alter 
the open complexes in Fig. 4A, B, although it is a 
strong inhibitor of rrnB P1 transcription. To 
visualize the effect of DksA better, we lowered the 
levels of RNAP to the point where a stable 
footprint was not well defined and then asked 
whether DksA or GreA altered the footprint. With 
RNAP present at 25 nM, adding 600 nM DksA 
(but not GreA) gave an increased level of 
protection in the presence of either GDP or ppGpp 
(Fig. 7). The protection afforded by DksA with 25 
nM RNAP seems to be nearly the equivalent of 50 
nM RNAP without DksA. This shows that stable 
open complexes are facilitated by DksA even at 
more dilute concentrations of RNAP (25 nM) than 
those in Fig.4B (50-100 nM). 
 
DISCUSSION 
 
Cellular experiments do not support a simple 
competition hypothesis. A simple prediction of the 
hypothesis tested here was that secondary channel 
interactions between GreA/B, DksA and RNAP 
dictate functional competition in transcription. The 
prediction is that changing the abundance of one 
protein should alter the regulatory effects of each 
of the others. 
Measurements of effects of mutation 
and/or overproduction of the three proteins on 
transcription of the rrnB P1 in vivo are not strictly 
consistent with this hypothesis. First, GreB 
overexpression during exponential growth does 
not alter activity, even if DksA is abolished by 
mutation. In contrast, overexpression of GreA 
activates this promoter, depending on the 
abundance of DksA. Second, overexpression of 
DksA inhibits activity of the same promoter 
independent of GreA levels. Nevertheless, there 
exists an antagonistic regulation between GreA 
and DksA. A high induced level of GreA in a dksA 
mutant, but not in dksA+, inhibits growth. The wild 
type level of DksA protects the cell against the 
potentially inhibitory effect of a high level of 
GreA. We believe growth inhibition by 
overproduction of a protein is common, but 
conditional inhibition depending on both 
overexpression of one protein and the absence of 
another protein is not. The cause of growth 
inhibition by excess GreA in the absence of DksA 
remains obscure.  
It is puzzling that DksA induction inhibits 
growth even in the absence of ppGpp (Fig. 1K), 
because it is a co-factor of DksA for the negative 
regulation of rRNA synthesis (see Introduction). 
We also find ppGpp to be required for DksA-
mediated transcription inhibition in vitro (Fig. 2). 
The explanation might relate to observations that 
very high (200x) molar ratios of DksA to RNAP 
inhibit rrnB P1 transcription in vitro even when 
ppGpp is absent (20). Nevertheless, the effects 
noted above on cell growth seem to reflect a need 
for a balance between the cellular content of GreA 
and DksA. This implies that an altered hypothesis 
might be that mutual competition between the 
three proteins is specified by unique binary 
combinations. Support for this possibility comes 
from two observations. First is that simultaneous 
overexpression of GreB and DksA reverses the 
growth toxicity of DksA without altering rrnB P1 
activity (Supplement Fig. S2). Second, 
overexpression of both GreA and DksA reverses 
inhibition of rrnB P1 activity (Supplement Fig. 
S2). 
The balance between these three proteins 
can also affect the arrest of rrnB P1 activity that 
normally occurs at A600 ~2 (Fig. 1A). This arrest 
is bypassed in the absence of DksA (Fig. 1B) or 
when high levels of GreA are induced in a wild 
type strain (Fig. 1A). It seems that the normal 
level of DksA prevents the normal level of GreA 
from activating rrnB P1 in stationary phase, just as 
it prevents GreA-mediated growth inhibition 
during exponential growth. GreB, when 
overexpressed, shares with GreA the ability to 
bypass the arrest of rrnB P1 transcription (Fig. 1E). 
Arrest of rrnB P1 transcription in wild type cells 
probably reflects entry into early stationary phase, 
since it requires both DksA and ppGpp (see 
results). Arrest of rrnB P1 activity is promoter 
specific because no arrest was observed with a 
lacUV5 promoter operon fusion in greA, greB, or 
dksA strains (data not shown). 
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We believe this is the first evidence that 
the balance of the three secondary channel binding 
proteins has functional significance and raises new 
possibilities for transcription regulation.  
 
Similarities and differences in vivo and in vitro, 
for GreA and DksA effects. A direct activating 
effect of GreA on transcription has been found. 
Maximal activation requires its presence during 
open complex formation. Multiple round 
transcription reactions reproduced the activation of 
rrnB P1 transcription by GreA to nearly the same 
extent (2.5x) as in vivo (3.4x); the ppGpp 
independence of this effect was also verified (Fig. 
2).  
Several parameters associated with 
initiation were not altered by GreA. The presence 
of GreA (or DksA) had no effect on the low level 
of abortive transcripts under all conditions of Fig. 
2A-D (data not shown). Also, measuring promoter 
escape by back extrapolating closely timed kinetic 
samples failed to reveal significant differences in 
the presence of GreA (data not shown). Finally, 
open complex stabilities, determined with a 
heparin challenge, were unaffected by the 
presence of GreA (data not shown). 
DksA added in parallel in vitro 
experiments allowed us to verify published 
observations of a co-factor requirement for ppGpp 
to inhibit rrnB P1 transcription (20). Mixtures of 
GreA and DksA presented simultaneously to 
RNAP at varying ratios to each other and to 
RNAP revealed that even brief exposures to DksA 
could inhibit and prevent or reverse GreA 
activation (Fig.3). Like DksA-mediated inhibition, 
this reversal of GreA activation was ppGpp-
dependent.  
 
DksA and GreA alter RNAP-DNA complex 
conformation. DNaseI footprints of RNAP with 
GreA and/or DksA and the rrnB P1 promoter 
DNA revealed the existence of a specific rrnB P1 
promoter binary open complex without the need 
for nucleotide substrates or accessory proteins (Fig. 
4A). This footprint persisted unchanged in the 
presence high DksA levels, with or without ppGpp, 
as if DksA did not destabilize the open complex. 
When GreA was substituted for DksA, the 
protection pattern was diminished, especially in 
the presence of ppGpp. The GreA-mediated 
change in DNaseI protection pattern was partially 
or completely reversed by DksA addition in the 
presence of ppGpp but not GDP. A change in the 
intensity of a footprint, without altering the extent 
of the protected region, could result from a change 
in RNAP promoter affinity. However, this 
possibility was ruled out by EMSA, where we did 
not observe decreased binding of RNAP to rrnB 
P1 region (Fig. 6). Instead we found that GreA 
even enhanced the formation of active RNAP-
DNA complexes in the presence of ATP and CTP 
(Fig. 6B). We therefore interpret the GreA-
induced change in the DNaseI footprint (Fig. 4A; 
Fig. 5AB) to represent a conformational change in 
the RNAP-promoter binary complex.  
Furthermore, the footprints imply that 
GreA acts before DksA during initiation, in the 
absence of NTPs, which is consistent with the 
order of addition experiments (Fig. 3C-F). 
Analogous footprints obtained in the presence of 
ATP and CTP were similar except that the 
footprint pattern with GreA was reversed at 
slightly different sequence positions by DksA. 
With ATP and CTP, GreA reversal now occurred 
in the presence of ppGpp and to a lesser extent in 
the presence of GDP (Fig. 4B; Fig. 5CD). Here, 
we are more confident of a conformational change 
because the extent of the footprint was changed by 
GreA, not just its intensity. This footprint covered 
only about 30 bp of DNA, which corresponds to 
expectations for an elongating complex (36). This 
difference is interesting, because without GreA 
present one would expect the first phosphodiester 
bond to be formed, and yet the footprint has an 
extent similar to an open binary complex. Perhaps, 
GreA by binding to RNAP in the presence of the 
two initiating nucleotides is able to tilt the balance 
from an open initiating complex toward an 
elongating complex. Alternatively, DksA 
inhibition may prevail despite a 20-fold molar 
excess of GreA (Fig. 3) because of a higher 
affinity of DksA for RNA polymerase than GreA 
as appears to be the case from Fig. 7. 
Apparently, GreA and DksA can exist in 
distinct complexes with RNAP and the rrnB P1 
promoter. As stated above, it seems that GreA can 
modify the conformation of RNAP complexes 
with DNA. It is important to note that the GreA 
effects we see on open complex conformation in 
the absence of NTP substrates are very different 
from previous reports that in the presence of NTP 
substrates GreA either stimulates the initiation 
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process after phosphodiester bond formation has 
begun (16, 37) or prevents the formation of 
inactive moribund complexes at the lambda pR 
promoter (38).  
DksA does not seem to change the 
conformation of the open complex, but when 
present with GreA, it restores a conformation that 
mimics what is seen when GreA is absent. It is 
interesting in this respect that DksA alone appears 
to decrease the amount of RNAP necessary to 
obtain a DNaseI footprint corresponding to an 
open complex (Fig. 7). This could mean that DksA 
facilitates DNA binding by RNAP, which could in 
turn occur by increasing the DNA binding 
constant (KB), or by increasing the transition 
between closed and open complex or by 
stabilizing the open complex. Two different 
approaches for estimating conformational change 
(EMSA and footprints), indicate that DksA does 
not cause the collapse of open complexes under 
our conditions. These observations conflict with 
existing views that DksA and ppGpp are thought 
to increase the instability of rrnB P1 open 
complexes and simultaneously weaken the binding 
for initiating nucleotides (20). An analogous 
finding to ours was reported by Maitra et al. (31), 
for a rpoC∆(312-314) mutant that suppresses 
ppGpp deficiency. Interpretations by Paul et al. 
(20) as to the instability of open complexes based 
upon the heparin chase experiments were 
challenged by the discovery of stable, but inactive 
promoter-RNAP binary complexes formed by this 
rpoC mutant. 
 
Considerations of GreA and DksA actions. The 
conclusion that GreA participates in initiation goes 
against existing information on its mode of action 
(Fig. 8). However there is evidence that GreA, 
unlike GreB, must be added before pausing 
actually occurs in order to activate cleavage of 
backtracked RNA (14). Perhaps there is a GreA 
binding site that is inaccessible in paused RNAP 
but accessible during initiation. The new finding 
here is that GreA can be bound during open 
complex formation (Fig. 8). It could even be 
imagined that GreA joins RNAP during initiation 
and is carried along during elongation to later 
perform its well established functions. This does 
not necessarily exclude the binding of GreA 
during elongation. Speculations about assembly of 
a GreA-containing transcription complex during 
initiation are reminiscent of eukaryotic 
transcription. Although the eukaryotic GreA 
homolog, TFIIS, is thought to bind RNAP during 
elongation, there is a report that it may play a role 
during initiation with Gal4-dependent promoters 
(39). 
If GreA assembles in such a complex, then 
either GreA binding does not obstruct the 
secondary channel or NTP entry can occur by an 
alternative route. Only GreB has been co-
crystallized with RNAP (9). Modeling of the 
docking of both GreA and DksA structures (1, 19) 
revealed that the key acidic residues of DksA 
require rotation to achieve the same orientation as 
in GreA and GreB. We wonder whether this 
orientation might determine activation for GreA or 
GreB and inhibition for DksA. Similar 
speculations have been raised by Lamour et al. (3) 
and Symersky et al. (4), in their work on Gfh1, a 
Thermus thermophilus Gre-like homolog 
responsible for transcription inhibition. Compared 
to GreA, there are four acidic residues in the Gfh1 
finger domain, which are again in a different 
orientation. The authors hypothesize that these 
residues impair transcription by chelating Mg2+ in 
the RNAP active site. Our finding that GreA 
activates transcription initiation suggests that 
additional studies are required before proposing a 
more detailed mechanism for GreA.  
If indeed GreA functions in initiation as 
argued here, it may be possible to obtain GreA 
mutants that differentially affect initiation but not 
elongation, or vice versa. GreA effects on open 
complex conformation before RNA diesters are 
formed might suggest that cleavage or the 
conserved acidic residues of GreA might not be 
activation requirements. Since GreA seems to act 
at the stage of transcription initiation, DksA in 
turn may exert unexpected additional effect on 
elongation. Although preliminary studies in vitro 
(19) seem to discourage this idea, a similar 
investigation in vivo may prove interesting.  
Finally, it was reported recently by 
Trautinger et al. (40) that deleting dksA sensitizes 
cells to mitomycin C. Intriguingly, introducing a 
greA deletion in addition to dksA reversed this 
phenotype, consistent with our proposal that GreA 
and DksA counteract each other’s actions. One of 
the most important implications of our finding is 
that cellular regulation of transcription can be 
achieved by a balance of antagonistic activities of 
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RNA polymerase secondary channel binding 
factors: DksA, GreA, and to a lesser degree GreB.  
 
 
While in the process of revising our 
manuscript, a publication by Susa et al. (41) 
appeared describing genes whose transcription 
was impaired by disrupting GreA and GreB. The 
mechanism explaining these effects is argued to be 
reversal of formation of abortive moribund 
complexes. It will be interesting to see if this 
process is related to the phenomenon we observed. 
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Figure Legends  
 
Fig.1. Overproduction of GreA, GreB, or DksA alters rrnB P1::lacZ activity. Using ∆lacZ strains 
carrying the rrnB P1::lacZ transcriptional fusion, we evaluated the effects of overproduction of GreA 
(panels A to D, strains transformed with pDNL278 = pgreA), GreB (panels E to H, strains transformed 
with pGF296 = pgreB), or DksA (panels I to L, strains transformed with pHM1506 = pdksA) on rrnB 
P1::lacZ activity. All strains were grown at 37°C; IPTG was added when the culture reached an OD600 of 
0.10- 0.15; β-galactosidase activity was monitored periodically. Squares: untransformed strains cultivated 
in LB. Filled diamonds: transformed strains cultivated in LB supplemented with ampicillin (panels A to 
H) or with spectinomycin (panels I to L). Circles: transformed strains cultivated in the same media 
supplemented with IPTG at 10-3 M (panels A, C and E to H), 10-4 M (panels I to L) or 10-5 M (panels B 
and D). Although lines showing arrest of activity for A600 ≥ 2.0 seem defined by a single point in panels 
A,E,I and J, the lines as drawn actually depend on more extensive data not shown. The ∆relA spoT+ 
strains are termed wild type here; equivalent results were obtained with relA+ spoT+ strains (data not 
shown). 
 
Fig. 2. Effects of GreA and DksA on in vitro transcription initiating from the rrnB P1 promoter 
depends on the order of addition. RNAP (30 nM) was pre-incubated with either 250 µM ppGpp (or 
GDP), and then: (A) pre-incubated with increasing concentrations of GreA or DksA (0-300 nM) and 
started by the addition of DNA (10 nM) and NTP substrates; (B) initiated by the simultaneous addition of 
DNA, NTPs, and GreA or DksA; (C) pre-incubated with DNA to allow for open complexes to form, and 
then initiated by the addition of NTPs together with GreA or DksA; (D) pre-incubated with both DNA 
and GreA or DksA, and then initiated by the addition of NTPs. Additional controls for all panels lacking 
GDP or ppGpp were similar to those with GDP. The standard deviation for all values was <10%. 
 
Fig. 3. GreA and DksA effects on rrnB P1 when added together. Transcription assays were performed 
as described in Fig. 2D, except that: (A) and (B) - increasing GreA concentrations (0-600 nM) were added 
simultaneously with DksA (0-600 nM) and NTPs as in 2C; reactions for panels C-F were single round 
under the conditions of Fig. 2D: (C) and (D) – GreA was added to the RNAP/DNA mix and the reaction 
was initiated by addition of NTPs with DksA; (E) and (F)- DksA was added first and the reaction was 
initiated by the addition of  NTPs with GreA. In panels (A), (C), and (E) assays were carried out in the 
presence of ppGpp; in panels (B), (D), and (F) GDP was substituted. 
 
Fig. 4. Footprinting analysis of RNAP protection at rrnB P1 in the presence of GreA and/or DksA. 
Reactions contained 3 nM double stranded template with the 3' end of the nontemplate strand labeled, 500 
µM ppGpp or GDP, and GreA and/or DksA. Amounts of RNAP present were 0, 50, or 100 nM The 
concentrations of the RNAP used are indicated at the top of the gel. Unlabeled lanes 1-3 = neither GreA, 
DksA, GDP, nor ppGpp present; lanes labeled 600 nM D - only DksA was present; lanes labeled 600 nM 
A - only GreA was present; A→ D - samples were pre-incubated with GreA and then DksA was added; 
(A + D) – both proteins were added simultaneously. Lanes labeled G,A,C, or T are sequencing ladders. 
Numbers at the right represent nucleotide positions relative to the start site. Panel A footprints were 
performed in the absence of NTP substrates while Panel B footprints were in the presence of ATP and 
CTP. This autoradiograph is lightly exposed to better visualize the differences between the footprints.     
 
Fig. 5. Quantitative scans of the individual lanes of the DNaseI I footprints.  Selected lanes from Fig. 
4 were quantitated by scanning densitometry. (A) Lanes with GDP from panel A of Fig. 4: RNAP with 
DksA alone (orange; lane 9), with GreA alone (red; lane 12), with GreA added first then DksA (yellow 
green; lane 15) and GreA together with DksA (green; lane 18). (B) Corresponding colors have been 
applied to lanes with ppGpp from Fig.4A (lanes 21, 24, 27 and 30). (C) A similar presentation applies to 
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analogous GDP control lanes from Fig.4B (lanes 8, 11, 14 and 17) as well as for (D) Footprint lanes with 
ppGpp from Fig.4B (20, 23, 26 and 29).  
 
Fig. 6. Electrophoretic mobility shift assays.  (A) Assays were performed with RNAP concentrations as 
shown: filled symbols- in the presence of ppGpp; open symbols- absence of ppGpp; RNAP alone – 
circles; RNAP with GreA- triangles. (B) As in panel A, but the reactions were carried out in the presence 
of the two initiating nucleotides, ATP and CTP. Quantitation is presented for the bands corresponding to 
the three complexes detected in each panel as well as for the amount of unbound DNA is presented. 
 
Fig. 7. DksA enhances RNAP binding to the rrnBP1 promoter region. (A) DNaseI footprinting was 
performed in the absence of ppGpp at varying RNAP concentrations as indicated at the top of the gel. (B) 
The assay was carried out at 25 nM RNAP, but in the presence of either 500 µM ppGpp or GDP; lanes 
labeled A - 600 nM GreA; lanes labeled D - 600 nM DksA; lanes labeled A+D - both GreA and DksA 
added. The ‘-‘ label denotes conditions where RNAP alone was employed. In all cases, the initiating 
nucleotides ATP and CTP were present to allow stable complex formation. Sequencing ladders are 
indicated. Numbers at the right represent nucleotide positions relative to the start site. The boxed regions 
of three lanes direct attention to regions allowing comparison of DksA protective effects at 25 nM RNAP 
concentrations. (C) Quantitative scans of the footprint shown in panel B with or without ppGpp, 
corresponding to lanes with RNAP alone (red), with GreA (yellow green), with DksA (orange) and with 
GreA and DksA together (green). 
 
Fig. 8. GreA acts at elongation as well as at initiation of transcription.  
(A) Generally accepted view that GreA acts at the stage of transcriptional elongation. (B) During initaiton 
GreA binds to RNAP and activates transcription (in a ppGpp-independent manner) at the rrnB P1 
promoter, at the stage of transcriptional complex assembly. During elongation, GreA may be carried 
along in the transcription complex or, if needed, a new GreA molecule may bind and rescue paused or 
arrested complexes, as in panel A. At the initiation stage DksA is able to overcome GreA’s effect and 
inhibit transcription in a ppGpp-dependent manner. 
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Table I. Data tabulated are differential rates of synthesis of β-galactosidase expressed in Miller units 
(Miller, 1972). These specific activities were calculated for the growth curve regions where absolute 
activities increase linearly with turbidity (Fig. 1). In parentheses are the relative rates, normalized to the 
wild type rate.   
 
 
 
Table I 
Genotype 
  
 
Plasmid 
 
 
relA 
greA 
relA  
dksA 
relA 
 
relA spoT 
greA 
relA spoT 
dksA 
relA spoT 
 
None 74 (≡1 x)   76 (1 x) 174 (2.4x) 92 (1.2x) 102 (1.4x) 173 (2.3x) 
pgreA 105 (1.4x)    - 250 (3.4x) 111 (1.5x) - 294 (4.0x) 
  " + IPTG 251 (3.4x)    - 211 (2.9x) 242 (3.3x) - 249 (3.4x) 
pgreB 67 (0.9x)    - 129 (1.7x) 94 (1.3x) - 154 (2.1x) 
  " + IPTG 111 (1.5x)    - 134 - 183 
(1.8x - 2.5x) 
133 (1.8x) - 161 - 213 
(2.2x -2.9x)
pdksA 50 (0.7x)   59 (0.8x) 101 (1.4x) 78 (1.1) 101 (1.4x)   - 
  " + IPTG < 5 
(< 0.07x) 
   < 5 
(< 0.07x) 
< 5 
(< 0.07x) 
< 5 
(< 0.07x) 
< 5 
(< 0.07x) 
  - 
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Fig.1. 
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Fig.2. 
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Fig.3. 
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Fig.4. 
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Fig. 8 
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